| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.36e-05 | 187 | 157 | 9 | GO:0007156 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | SDK2 PCDHA9 DSCAM TRO PCDHB5 KLF4 PCDHB18P PKD1 TENM1 DCHS1 PCDH8 | 2.89e-05 | 313 | 157 | 11 | GO:0098742 |
| GeneOntologyBiologicalProcess | cerebellar cortex morphogenesis | 3.15e-05 | 48 | 157 | 5 | GO:0021696 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | FRAS1 SHROOM3 KLF4 AR MAP3K1 TGFB1I1 NFATC3 TRIM28 PKD1 DCHS1 HECTD1 PCDH8 MRTFA TBX2 PROX1 | 7.97e-05 | 619 | 157 | 15 | GO:0002009 |
| GeneOntologyBiologicalProcess | cerebellum morphogenesis | 9.34e-05 | 60 | 157 | 5 | GO:0021587 | |
| GeneOntologyBiologicalProcess | cell differentiation in hindbrain | 9.84e-05 | 32 | 157 | 4 | GO:0021533 | |
| GeneOntologyBiologicalProcess | cerebellar cortex formation | 1.25e-04 | 34 | 157 | 4 | GO:0021697 | |
| GeneOntologyBiologicalProcess | hindbrain morphogenesis | 1.27e-04 | 64 | 157 | 5 | GO:0021575 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FRAS1 SHROOM3 PCNX3 BICRA C19orf47 FBRSL1 KDM3B ICE1 KLF4 POM121C PRAG1 CNTROB ITGB4 ABCA7 CIC KCNH3 CABLES1 GGA3 ZNF503 PRR12 KMT2C EPS15L1 RPAP1 GAREM2 TMEM259 TRIM28 AHNAK ZMIZ2 PKD1 MLLT6 PKN1 IRS2 ULK1 DOT1L SSBP4 MAPKBP1 HECTD1 | 2.21e-21 | 1105 | 162 | 37 | 35748872 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CHAF1B TCOF1 KDM3B CIC MEF2D PASK USP10 EPS15L1 RPAP1 GSE1 SEC24C ZC3H4 TRIM28 SIPA1L1 CCNL1 DYNC1LI1 CCAR2 PKN1 IRS2 BAG6 SF3B2 MRTFA VCPIP1 | 1.92e-12 | 774 | 162 | 23 | 15302935 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SHROOM3 TBC1D5 C19orf47 KDM3B CBARP PRAG1 CIC MEF2D ITPKB RUSC2 NEK1 NFATC3 AHNAK SIPA1L1 AKAP11 SRPK3 IRS2 HECTD1 SH3RF3 MEX3B TNS3 VCPIP1 | 1.09e-10 | 861 | 162 | 22 | 36931259 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SHROOM3 TCOF1 BICRA TRO TBC1D5 POM121C CIC MAP3K1 GGA3 TGFB1I1 PRR14 ATXN2 ZMIZ2 MLLT6 MEX3B MRTFA | 2.18e-10 | 430 | 162 | 16 | 35044719 |
| Pubmed | SHROOM3 DSCAM HCN4 TCOF1 TBC1D5 USP10 EPS15L1 SEC24C ATXN2 NFATC3 TMEM259 LZTS1 ZC3H4 TRIM28 SIPA1L1 DCHS1 CCAR2 PKN1 TNS1 PCDH8 PROX1 | 4.99e-09 | 963 | 162 | 21 | 28671696 | |
| Pubmed | UBQLN4 ICE1 CIC RBM20 PRR12 NEK1 GSE1 WDR6 AHNAK ZMIZ2 IRS2 MRTFA VCPIP1 PROX1 | 1.16e-08 | 418 | 162 | 14 | 34709266 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | ZSWIM8 ROGDI TCOF1 TBC1D5 FBRSL1 KDM3B CNTROB MEF2D MAP3K1 RUSC2 TGFB1I1 PASK NEK1 EPS15L1 RPAP1 SEC24C CLPB CCAR2 IRS2 MRTFA TNS3 | 1.82e-08 | 1038 | 162 | 21 | 26673895 |
| Pubmed | Interaction network of human early embryonic transcription factors. | ARGFX BICRA FBRSL1 POM121C ZNF503 PRR12 KMT2C GSE1 WDR6 ZMIZ2 PBX2 TBX2 | 1.07e-07 | 351 | 162 | 12 | 38297188 |
| Pubmed | SHROOM3 SDK2 FBRSL1 KDM3B ICE1 GGA3 PASK USP10 KMT2C ZC3H4 CNTNAP2 MED12L AKAP11 DAGLA | 2.12e-07 | 529 | 162 | 14 | 14621295 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | ZSWIM8 CACNA2D2 LRRC32 KDM3B MUC16 ZC3HC1 POM121C CIC PRR12 AHNAK TENM1 AKAP11 VWA2 TNS1 | 3.53e-07 | 552 | 162 | 14 | 10737800 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TCOF1 TBC1D5 KDM3B ICE1 POM121C CIC GGA3 USP10 NEK1 EPS15L1 PDLIM3 GSE1 ZC3H4 TRIM28 AHNAK IRS2 SF3B2 VCPIP1 | 4.14e-07 | 934 | 162 | 18 | 33916271 |
| Pubmed | TCOF1 BICRA UBQLN4 KDM3B ZNF503 ATXN2 ZC3H4 AHNAK DYNC1LI1 CCAR2 BAG6 SF3B2 | 4.23e-07 | 399 | 162 | 12 | 35987950 | |
| Pubmed | FRAS1 TRO GGA3 RUSC2 RPAP1 GSE1 SEC24C SIPA1L1 CCAR2 ULK1 MAPKBP1 VCPIP1 | 5.21e-07 | 407 | 162 | 12 | 12693553 | |
| Pubmed | TCOF1 ZC3HC1 ITGB4 MEF2D CABLES1 USP10 EPS15L1 ZC3H4 TRIM28 PKN1 IRS2 BAG6 MRTFA | 7.61e-07 | 503 | 162 | 13 | 16964243 | |
| Pubmed | Global comparative transcriptome analysis of cartilage formation in vivo. | 7.90e-07 | 16 | 162 | 4 | 19272164 | |
| Pubmed | 1.21e-06 | 225 | 162 | 9 | 12168954 | ||
| Pubmed | FRAS1 EPB41L4B TBC1D5 FBRSL1 KDM3B RBM20 RUSC2 PRR12 RPAP1 GSE1 ZC3H4 WDR6 ULK1 SF3B2 | 2.41e-06 | 650 | 162 | 14 | 38777146 | |
| Pubmed | 2.53e-06 | 246 | 162 | 9 | 15345747 | ||
| Pubmed | BICRA LAMA3 NCKAP5 NUP42 POM121C ITGB4 CIC MEF2D DES KMT2C TRIM28 TNS1 | 3.28e-06 | 486 | 162 | 12 | 20936779 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | ARGFX MEIS3 KLF4 FOXA3 AR CIC MEF2D HOXB1 FOXD3 KLF1 NFATC3 DMRTA2 LHX5 PBX2 TBX2 PROX1 | 5.88e-06 | 908 | 162 | 16 | 19274049 |
| Pubmed | ZSWIM8 TRO TBC1D5 UBQLN4 CNTROB ITGB4 CIC TGFB1I1 ATXN2 MLLT6 MAPKBP1 PCDH8 BAG6 | 6.05e-06 | 608 | 162 | 13 | 16713569 | |
| Pubmed | 6.26e-06 | 26 | 162 | 4 | 28082864 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EP400P1 SHROOM3 RASA1 CACNA2D2 EPB41L4B BICRA TBC1D5 FBRSL1 LAMA3 MEIS3 AR ITPKB USP10 KMT2C EPS15L1 ATXN2 PKN1 PBX2 HECTD1 SH3RF3 DAGLA | 6.33e-06 | 1489 | 162 | 21 | 28611215 |
| Pubmed | 7.67e-06 | 152 | 162 | 7 | 38360978 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | ARGFX MEIS3 KLF4 FOXA3 MEF2D HOXB1 FOXD3 NFATC3 DMRTA2 LHX5 TBX2 PROX1 | 1.02e-05 | 544 | 162 | 12 | 28473536 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NUP42 POM121C CIC RBM20 MEF2D ZNF503 PRR12 KMT2C PRR14 GSE1 ATXN2 | 1.08e-05 | 457 | 162 | 11 | 32344865 |
| Pubmed | TCOF1 KDM3B GGA3 USP10 KMT2C NEK1 EPS15L1 TRIM28 WDR6 AHNAK DOT1L VCPIP1 | 1.12e-05 | 549 | 162 | 12 | 38280479 | |
| Pubmed | Mapping of the mouse hyh gene to a YAC/BAC contig on proximal Chromosome 7. | 1.16e-05 | 10 | 162 | 3 | 12016511 | |
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 25487574 | ||
| Pubmed | BICRA FBRSL1 KLF4 POM121C CIC RBM20 MEF2D ZNF503 PRR12 RNF214 KMT2C GSE1 ATXN2 NFATC3 ZMIZ2 CCAR2 MLLT6 DOT1L SSBP4 PBX2 | 1.20e-05 | 1429 | 162 | 20 | 35140242 | |
| Pubmed | SHROOM3 DSCAM TCOF1 EPB41L4B KDM3B MUC16 ZC3HC1 CBARP EPS15L1 SEC24C ZC3H4 AHNAK CCAR2 PKN1 | 1.81e-05 | 777 | 162 | 14 | 35844135 | |
| Pubmed | EP400P1 ZSWIM8 CHAF1B TCOF1 BICRA FBRSL1 POM121C ABCA7 PASK GSE1 ZC3H4 TRIM28 WDR6 SIPA1L1 IRS2 TBX2 PROX1 | 1.96e-05 | 1116 | 162 | 17 | 31753913 | |
| Pubmed | ZSWIM8 CHAF1B PCNX3 KDM3B PRDM8 CLPB ZC3H4 WDR6 PKD1 ETNK1 CCAR2 ULK1 ARHGAP27 SSBP4 PBX2 TBX2 | 2.07e-05 | 1006 | 162 | 16 | 15226823 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | RASA1 UBQLN4 ZC3HC1 ICE1 PRAG1 BCS1L CIC CCDC85A TGFB1I1 KMT2C PRR14 PKN1 TNS1 PCDH8 BAG6 MEX3B SF3B2 | 2.15e-05 | 1124 | 162 | 17 | 21900206 |
| Pubmed | SF3B2-Mediated RNA Splicing Drives Human Prostate Cancer Progression. | 2.16e-05 | 2 | 162 | 2 | 31431456 | |
| Pubmed | Two new cases of interstitial 7q35q36.1 deletion including CNTNAP2 and KMT2C. | 2.16e-05 | 2 | 162 | 2 | 34582124 | |
| Pubmed | MLL3 suppresses tumorigenesis through regulating TNS3 enhancer activity. | 2.16e-05 | 2 | 162 | 2 | 33824309 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 35954177 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 26249023 | ||
| Pubmed | In vivo intra-articular contrast enhanced μCT imaging of mouse knee cartilage. | 2.16e-05 | 2 | 162 | 2 | 36436817 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 27113755 | ||
| Pubmed | The ubiquitin-specific protease USP10 modulates androgen receptor function. | 2.16e-05 | 2 | 162 | 2 | 16368182 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 30658712 | ||
| Pubmed | Regulation of corneal epithelial barrier function by Kruppel-like transcription factor 4. | 2.16e-05 | 2 | 162 | 2 | 21051695 | |
| Pubmed | The Role of Dot1l in Prenatal and Postnatal Murine Chondrocytes and Trabecular Bone. | 2.16e-05 | 2 | 162 | 2 | 32083237 | |
| Pubmed | Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate. | 2.16e-05 | 2 | 162 | 2 | 10075738 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 16809425 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 11155740 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 12514133 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 14521927 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 29348458 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 24440747 | ||
| Pubmed | A direct androgenic involvement in the expression of human corticotropin-releasing hormone. | 2.16e-05 | 2 | 162 | 2 | 16446741 | |
| Pubmed | 2.66e-05 | 37 | 162 | 4 | 19266077 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 2.88e-05 | 256 | 162 | 8 | 33397691 | |
| Pubmed | ZSWIM8 CHAF1B DSCAM TCOF1 UBQLN4 ZBTB47 NCKAP5 NUP42 CCDC85A EPS15L1 CLPB SIPA1L1 PKD1 PBX2 HECTD1 SF3B2 JPH3 VCPIP1 | 3.33e-05 | 1285 | 162 | 18 | 35914814 | |
| Pubmed | 3.48e-05 | 263 | 162 | 8 | 20932939 | ||
| Pubmed | 3.98e-05 | 268 | 162 | 8 | 33640491 | ||
| Pubmed | Hundreds of variants clustered in genomic loci and biological pathways affect human height. | 4.22e-05 | 198 | 162 | 7 | 20881960 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | EPB41L4B MUC19 ICE1 AMER3 ZNF831 CABLES1 TGFB1I1 KMT2C RPAP1 GSE1 AHNAK PKD1 PBX2 | 4.45e-05 | 736 | 162 | 13 | 29676528 |
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 4.73e-05 | 84 | 162 | 5 | 15203218 | |
| Pubmed | Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome. | 4.86e-05 | 43 | 162 | 4 | 34672947 | |
| Pubmed | 5.31e-05 | 16 | 162 | 3 | 21266775 | ||
| Pubmed | 5.94e-05 | 209 | 162 | 7 | 36779422 | ||
| Pubmed | 6.45e-05 | 3 | 162 | 2 | 20923779 | ||
| Pubmed | RASA1 maintains the lymphatic vasculature in a quiescent functional state in mice. | 6.45e-05 | 3 | 162 | 2 | 22232212 | |
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 6.45e-05 | 3 | 162 | 2 | 30802453 | |
| Pubmed | 6.45e-05 | 3 | 162 | 2 | 29249800 | ||
| Pubmed | 6.45e-05 | 3 | 162 | 2 | 30513362 | ||
| Pubmed | 6.45e-05 | 3 | 162 | 2 | 11971970 | ||
| Pubmed | 6.45e-05 | 3 | 162 | 2 | 35507432 | ||
| Pubmed | Inositol 1,3,4,5-tetrakisphosphate is essential for T lymphocyte development. | 6.45e-05 | 3 | 162 | 2 | 14517551 | |
| Pubmed | AMACO is a component of the basement membrane-associated Fraser complex. | 6.45e-05 | 3 | 162 | 2 | 24232570 | |
| Pubmed | 6.45e-05 | 3 | 162 | 2 | 8499623 | ||
| Pubmed | Structural Basis of Diverse Homophilic Recognition by Clustered α- and β-Protocadherins. | 6.45e-05 | 3 | 162 | 2 | 27161523 | |
| Pubmed | Krüppel-like Factor 4 activates HBG gene expression in primary erythroid cells. | 6.45e-05 | 3 | 162 | 2 | 21539536 | |
| Pubmed | 6.45e-05 | 3 | 162 | 2 | 23598283 | ||
| Pubmed | 6.45e-05 | 3 | 162 | 2 | 11856738 | ||
| Pubmed | Globular domains 4/5 of the laminin alpha3 chain mediate deposition of precursor laminin 5. | 6.45e-05 | 3 | 162 | 2 | 15316072 | |
| Pubmed | 6.45e-05 | 3 | 162 | 2 | 31857500 | ||
| Pubmed | 6.45e-05 | 3 | 162 | 2 | 22373577 | ||
| Pubmed | 6.45e-05 | 3 | 162 | 2 | 14559359 | ||
| Pubmed | A HIC-5- and KLF4-dependent mechanism transactivates p21(Cip1) in response to anchorage loss. | 6.45e-05 | 3 | 162 | 2 | 23007394 | |
| Pubmed | Abnormal features in mutant cerebellar Purkinje cells lacking junctophilins. | 6.45e-05 | 3 | 162 | 2 | 17904530 | |
| Pubmed | RASA1 regulates the function of lymphatic vessel valves in mice. | 6.45e-05 | 3 | 162 | 2 | 28530642 | |
| Pubmed | Positive regulation of β-catenin-PROX1 signaling axis by DBC1 in colon cancer progression. | 6.45e-05 | 3 | 162 | 2 | 26477307 | |
| Pubmed | 6.45e-05 | 3 | 162 | 2 | 19126541 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | MEIS3 FOXA3 AR CIC TGFB1I1 HOXB1 NFATC3 TRIM28 LHX5 SSBP4 PBX2 MRTFA TBX2 PROX1 | 6.68e-05 | 877 | 162 | 14 | 20211142 |
| Pubmed | 6.94e-05 | 91 | 162 | 5 | 20546612 | ||
| Pubmed | TCOF1 TBC1D5 KDM3B GGA3 EPS15L1 CLPB AHNAK HECTD1 BAG6 VCPIP1 | 9.28e-05 | 481 | 162 | 10 | 28190767 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ZSWIM8 TCOF1 C19orf47 FBRSL1 NUP42 CIC RBM20 GSE1 NFATC3 DOT1L VCPIP1 | 1.05e-04 | 588 | 162 | 11 | 38580884 |
| Pubmed | ROGDI KDM3B NUP42 KLF4 CIC MEF2D PRR14 TRIM28 ZMIZ2 MLLT6 PBX2 SF3B2 MRTFA | 1.13e-04 | 808 | 162 | 13 | 20412781 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | ZSWIM8 NUTM2D MEIS3 CNTROB ITGB4 TGFB1I1 EPS15L1 GSE1 CLPB NFATC3 AHNAK PKD1 SSBP4 MRTFA | 1.17e-04 | 925 | 162 | 14 | 28986522 |
| Pubmed | Regulation of skeletal muscle sarcomere integrity and postnatal muscle function by Mef2c. | 1.24e-04 | 21 | 162 | 3 | 17875930 | |
| Pubmed | 1.29e-04 | 4 | 162 | 2 | 22087315 | ||
| Pubmed | 1.29e-04 | 4 | 162 | 2 | 21924870 | ||
| Pubmed | Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes. | 1.29e-04 | 4 | 162 | 2 | 17900573 | |
| Pubmed | Junctophilin-mediated channel crosstalk essential for cerebellar synaptic plasticity. | 1.29e-04 | 4 | 162 | 2 | 17347645 | |
| Pubmed | 1.29e-04 | 4 | 162 | 2 | 19864429 | ||
| Pubmed | 1.29e-04 | 4 | 162 | 2 | 21637844 | ||
| Interaction | TOP3B interactions | FRAS1 SHROOM3 PCNX3 BICRA C19orf47 FBRSL1 KDM3B ICE1 KLF4 POM121C PRAG1 CNTROB ITGB4 ABCA7 CIC KCNH3 CABLES1 GGA3 ZNF503 PRR12 USP10 KMT2C EPS15L1 RPAP1 GAREM2 ATXN2 TMEM259 TRIM28 AHNAK ZMIZ2 PKD1 MLLT6 PKN1 IRS2 ULK1 DOT1L SSBP4 MAPKBP1 HECTD1 MEX3B | 2.51e-12 | 1470 | 159 | 40 | int:TOP3B |
| Interaction | PAX9 interactions | 9.21e-07 | 130 | 159 | 9 | int:PAX9 | |
| Interaction | PAX7 interactions | 6.38e-06 | 124 | 159 | 8 | int:PAX7 | |
| Interaction | PAX6 interactions | DSCAM BICRA FBRSL1 AR CIC STAC ZNF503 PRR12 HOXB1 KMT2C GSE1 MLLT6 PROX1 | 7.00e-06 | 366 | 159 | 13 | int:PAX6 |
| Interaction | DYRK1B interactions | 7.74e-06 | 91 | 159 | 7 | int:DYRK1B | |
| Interaction | GCM1 interactions | 1.60e-05 | 68 | 159 | 6 | int:GCM1 | |
| Interaction | TLX3 interactions | FBRSL1 AR CIC ZNF503 TGFB1I1 PRR12 KMT2C GSE1 ZMIZ2 CCAR2 PBX2 | 2.05e-05 | 291 | 159 | 11 | int:TLX3 |
| Interaction | YWHAQ interactions | SHROOM3 TBC1D5 UBQLN4 C19orf47 CBARP ITGB4 AR CIC MEF2D MAP3K1 RUSC2 DES NEK1 CLPB NFATC3 TRIM28 SIPA1L1 CCAR2 AKAP11 IRS2 HECTD1 VWA2 TNS3 | 2.33e-05 | 1118 | 159 | 23 | int:YWHAQ |
| Interaction | SP7 interactions | BICRA FBRSL1 CIC RBM20 MEF2D ZNF503 PRR12 KMT2C GSE1 ZMIZ2 PBX2 | 3.07e-05 | 304 | 159 | 11 | int:SP7 |
| Interaction | TLE3 interactions | FBRSL1 FOXA3 AR CIC RBM20 ZNF503 PRR12 GSE1 ZMIZ2 MLLT6 DOT1L SSBP4 | 4.55e-05 | 376 | 159 | 12 | int:TLE3 |
| Interaction | SMG7 interactions | ZSWIM8 RBM20 MEF2D PRR12 RNF214 GSE1 ATXN2 ZC3H4 MLLT6 DOT1L MEX3B | 4.75e-05 | 319 | 159 | 11 | int:SMG7 |
| Interaction | YWHAB interactions | CHAF1B SHROOM3 TBC1D5 CBARP ITGB4 CIC STAC ITPKB RUSC2 NEK1 NFATC3 SIPA1L1 DYNC1LI1 AKAP11 IRS2 DOT1L HECTD1 VWA2 SH3RF3 MEX3B TNS3 | 4.97e-05 | 1014 | 159 | 21 | int:YWHAB |
| Interaction | PCDH8 interactions | 5.55e-05 | 10 | 159 | 3 | int:PCDH8 | |
| Interaction | IRF4 interactions | 5.74e-05 | 85 | 159 | 6 | int:IRF4 | |
| Interaction | ERG interactions | 7.16e-05 | 223 | 159 | 9 | int:ERG | |
| Interaction | TLX1 interactions | 7.67e-05 | 175 | 159 | 8 | int:TLX1 | |
| Interaction | CEBPZ interactions | ZBTB47 ZNF692 TRIM28 WDR6 SRPK3 DOT1L HECTD1 BAG6 SF3B2 PROX1 | 8.14e-05 | 281 | 159 | 10 | int:CEBPZ |
| Interaction | PHF21A interactions | 9.09e-05 | 343 | 159 | 11 | int:PHF21A | |
| Interaction | USP10 interactions | 1.06e-04 | 290 | 159 | 10 | int:USP10 | |
| Interaction | AR interactions | RASA1 KDM3B KLF4 AR CIC MEF2D TGFB1I1 PRR12 USP10 KMT2C GSE1 ZC3H4 TRIM28 ZMIZ2 MED12L CCAR2 DOT1L TNS1 BAG6 SF3B2 | 1.10e-04 | 992 | 159 | 20 | int:AR |
| Interaction | GATA3 interactions | 1.22e-04 | 187 | 159 | 8 | int:GATA3 | |
| Interaction | UBAP2L interactions | FBRSL1 AR RNF214 USP10 ATXN2 TRIM28 CNTNAP2 PHLPP1 HECTD1 MEX3B | 1.32e-04 | 298 | 159 | 10 | int:UBAP2L |
| Interaction | HNF1B interactions | 1.36e-04 | 190 | 159 | 8 | int:HNF1B | |
| Interaction | YWHAE interactions | CHAF1B SHROOM3 TBC1D5 ZC3HC1 CBARP PRAG1 CIC STAC MAP3K1 RUSC2 NEK1 TRIM28 SIPA1L1 DYNC1LI1 CCAR2 AKAP11 IRS2 ULK1 DOT1L HECTD1 SH3RF3 MEX3B SF3B2 | 1.37e-04 | 1256 | 159 | 23 | int:YWHAE |
| Interaction | YWHAH interactions | SHROOM3 TBC1D5 C19orf47 KDM3B CBARP PRAG1 CIC MEF2D RUSC2 NEK1 NFATC3 AHNAK SIPA1L1 CCAR2 AKAP11 IRS2 HECTD1 SH3RF3 MEX3B TNS3 VCPIP1 | 1.60e-04 | 1102 | 159 | 21 | int:YWHAH |
| Interaction | KLF5 interactions | 1.62e-04 | 195 | 159 | 8 | int:KLF5 | |
| Interaction | GTF3C4 interactions | 1.62e-04 | 195 | 159 | 8 | int:GTF3C4 | |
| Interaction | HDAC1 interactions | UBQLN4 KLF4 AR CIC RBM20 MEF2D NEK1 GSE1 KLF1 TRIM28 WDR6 AHNAK ZMIZ2 PHLPP1 CCAR2 IRS2 DOT1L HECTD1 SF3B2 MRTFA VCPIP1 | 1.72e-04 | 1108 | 159 | 21 | int:HDAC1 |
| Cytoband | 10q22.2 | 4.17e-04 | 41 | 162 | 3 | 10q22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 6.98e-04 | 298 | 162 | 6 | chr5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 7.20e-04 | 415 | 162 | 7 | chr12q24 | |
| Cytoband | 5q31 | 7.62e-04 | 115 | 162 | 4 | 5q31 | |
| Cytoband | 8q13 | 7.98e-04 | 12 | 162 | 2 | 8q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q35 | 1.17e-03 | 129 | 162 | 4 | chr2q35 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 8.97e-04 | 8 | 104 | 2 | 837 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 9.72e-04 | 34 | 104 | 3 | 487 | |
| GeneFamily | Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases | 1.15e-03 | 9 | 104 | 2 | 90 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.38e-03 | 161 | 104 | 5 | 593 | |
| GeneFamily | SH2 domain containing | 2.75e-03 | 101 | 104 | 4 | 741 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | TCOF1 BICRA FBRSL1 CNTROB ZNF692 ABCA7 CIC MEF2D RNF214 TMEM259 ZMIZ2 CCAR2 DOT1L PBX2 | 2.66e-08 | 338 | 162 | 14 | M17094 |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 4.34e-06 | 199 | 162 | 9 | M9443 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | SDK2 TCOF1 TRO LAMA3 ITGB4 STAC RUSC2 TGFB1I1 PKD1 DCHS1 TNS1 TBX2 ARMH4 | 9.46e-06 | 479 | 162 | 13 | M2573 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | SDK2 TCOF1 TRO LAMA3 ITGB4 STAC RUSC2 TGFB1I1 PKD1 DCHS1 TNS1 TBX2 ARMH4 | 1.03e-05 | 483 | 162 | 13 | MM1082 |
| Coexpression | GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP | 2.60e-05 | 191 | 162 | 8 | M4164 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | JPH4 DSCAM MUC19 AMER3 CCDC85A GSE1 CNTNAP2 TENM1 MED12L DOT1L PDE11A PROX1 | 3.44e-05 | 465 | 162 | 12 | M39066 |
| Coexpression | GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_DN | 3.49e-05 | 199 | 162 | 8 | M9701 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN | 3.62e-05 | 200 | 162 | 8 | M6583 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP | 3.88e-05 | 202 | 162 | 8 | M38982 | |
| Coexpression | GRADE_COLON_AND_RECTAL_CANCER_DN | 4.19e-05 | 102 | 162 | 6 | M15780 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 5.11e-05 | 210 | 162 | 8 | M2010 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | ROGDI C19orf47 ISLR POM121C ITGB4 ZNF503 NFATC3 AHNAK ZMIZ2 ULK1 ARHGAP27 MAPKBP1 POM121B TBX2 | 5.23e-05 | 647 | 162 | 14 | MM981 |
| Coexpression | YAGUE_PRETUMOR_DRUG_RESISTANCE_DN | 6.33e-05 | 13 | 162 | 3 | M2070 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 6.43e-05 | 217 | 162 | 8 | MM861 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | DSCAM CACNA2D2 AMER3 CRH DES HOXB1 FOXD3 PRDM8 ACAN CSPG5 LHX5 PCDH8 JPH3 | 8.28e-05 | 591 | 162 | 13 | M2019 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | DSCAM CACNA2D2 AMER3 CRH DES HOXB1 FOXD3 PRDM8 ACAN CSPG5 LHX5 PCDH8 JPH3 | 9.79e-05 | 601 | 162 | 13 | MM866 |
| Coexpression | GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN | 1.20e-04 | 177 | 162 | 7 | M8666 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD | 1.30e-04 | 125 | 162 | 6 | M38988 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP | 1.49e-04 | 385 | 162 | 10 | M2840 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.57e-08 | 146 | 162 | 8 | 47368f981180ca6a8c81a50f7f9430f12456f609 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_immature_neuronal_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.40e-07 | 161 | 162 | 8 | bb9cb42882aaa4a1ecf9b480c0e7ac302f2c0d5d | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.94e-07 | 168 | 162 | 8 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.65e-07 | 175 | 162 | 8 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.89e-07 | 177 | 162 | 8 | fdab7b7ddfb06f913b8224c0c80574dc3cf4cbd4 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-07 | 179 | 162 | 8 | 479116ac65488c60104a053530830763ec1f95b2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-07 | 179 | 162 | 8 | 1dfc0cb8b369aef35c59f3d4c52603dc9f3728c1 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-07 | 179 | 162 | 8 | 69a1b3b05c921de6343ffe6ad998aa2b804312a7 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.57e-07 | 182 | 162 | 8 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.57e-07 | 182 | 162 | 8 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.72e-07 | 183 | 162 | 8 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.88e-07 | 184 | 162 | 8 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-07 | 195 | 162 | 8 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.26e-07 | 196 | 162 | 8 | 50aaca81b593ff71790bb75403b2e4c3ab03a6d2 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.50e-07 | 197 | 162 | 8 | ff4df77117165b6b25315e29b0722cc136eba607 | |
| ToppCell | (2)_5-FU-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 6.50e-07 | 197 | 162 | 8 | 434ae0231972acba12d06279908cf407e70511ac | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.76e-07 | 198 | 162 | 8 | 62059185afdf66126a6fbc899ce611c47e7a0feb | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 6.76e-07 | 198 | 162 | 8 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | 18-Airway-Epithelial-Goblet-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 1.50e-06 | 153 | 162 | 7 | 14a60220e169ce642771636de982a7b02e5b2608 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.11e-06 | 161 | 162 | 7 | be77e99faf653480c166305df3a4e93db76f0dcb | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C|TCGA-Thymus / Sample_Type by Project: Shred V9 | 2.29e-06 | 163 | 162 | 7 | 2dac87d15051151ccf193760ddd8b82534c3f922 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.48e-06 | 165 | 162 | 7 | c6b23013d77fa9aa967b76e451c8e42b0a657c30 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-06 | 166 | 162 | 7 | 548d0d6c0ffd564036ddba78620734220ebb73d7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-06 | 166 | 162 | 7 | 80e164a89d22098cabe4a99a78283ba69ea0561e | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.59e-06 | 166 | 162 | 7 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.03e-06 | 170 | 162 | 7 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.10e-06 | 178 | 162 | 7 | c982a73955c9c193bcab21d60d453afcc09cd586 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.41e-06 | 180 | 162 | 7 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.41e-06 | 180 | 162 | 7 | 2ccc77d769d3ffd77ab3af45e4f192785b6db79c | |
| ToppCell | Pericytes-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.92e-06 | 183 | 162 | 7 | 4617b18da8d699a44e4c47980197b1e7eb951470 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.10e-06 | 184 | 162 | 7 | c7073d1b2c4fdb154d87678b92a0629c02116972 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.10e-06 | 184 | 162 | 7 | 1ed558a88215b248431c524ea16f13d9022ae98c | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.28e-06 | 185 | 162 | 7 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.28e-06 | 185 | 162 | 7 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.47e-06 | 186 | 162 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.47e-06 | 186 | 162 | 7 | cf96f880e6e22189593ce1357c55e65c34644559 | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.67e-06 | 187 | 162 | 7 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.08e-06 | 189 | 162 | 7 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | critical-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.29e-06 | 190 | 162 | 7 | 05a2c3549b68f49081723bf35db14974274419d5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-06 | 192 | 162 | 7 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-06 | 192 | 162 | 7 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.97e-06 | 193 | 162 | 7 | 5182284dfa7c94027e94172e08f78c86b95d63f4 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.97e-06 | 193 | 162 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.97e-06 | 193 | 162 | 7 | 4f7bab0115469c855160636d168bd6e5d4e2dd2f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Cajal_Retzius-36|World / Primary Cells by Cluster | 7.46e-06 | 195 | 162 | 7 | bc76a0586cc78f013cb96a2444e63e3c5daa3bc7 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Cajal_Retzius|World / Primary Cells by Cluster | 7.46e-06 | 195 | 162 | 7 | 424d8e2bc7f7e68f74219de06dbbb671c8b4c24c | |
| ToppCell | tumor_Lung-Fibroblasts-Smooth_muscle_cells|tumor_Lung / Location, Cell class and cell subclass | 7.46e-06 | 195 | 162 | 7 | ea9ff25020c2fcd1bab80e1829af0f4e4777de8b | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.71e-06 | 196 | 162 | 7 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 7.97e-06 | 197 | 162 | 7 | f7ef62d78336812573148f8bfce401877ec4e29c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.19e-06 | 130 | 162 | 6 | 56b9c3325e011f1dbaf9efc71bd6e1af4f96fda6 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.24e-06 | 198 | 162 | 7 | 0f1feed8a37293ae02465909f99548ab58dc7ce5 | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.79e-06 | 200 | 162 | 7 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial|10w / Sample Type, Dataset, Time_group, and Cell type. | 8.79e-06 | 200 | 162 | 7 | ff0b2675c68e9fc1fa16b3276431f199f3642eac | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.79e-06 | 200 | 162 | 7 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.79e-06 | 200 | 162 | 7 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-LBH|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.79e-06 | 200 | 162 | 7 | 0ff2607c58bc929e203f407ecf3605e0b21bfa90 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-SERPINF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.79e-06 | 200 | 162 | 7 | c4e08cf539c12bb7c61be6d44b4f074bb460f526 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.79e-06 | 200 | 162 | 7 | 140aff451cd58e1d544ee668e49e37e577f6f068 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 8.79e-06 | 200 | 162 | 7 | 07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-SERPINF1-L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.79e-06 | 200 | 162 | 7 | f922f9f223cbfed71b8e3115b16b51dc4d7b66b8 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-LBH-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.79e-06 | 200 | 162 | 7 | de23a5d22d94935802b5b84a9e029b3f62c57028 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.79e-06 | 200 | 162 | 7 | 85bfa7f4dd07a4d4a88330e88f5886fd1ecfdeeb | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.23e-05 | 155 | 162 | 6 | cba6f3f7742b4d5d54ad0a0ac0dd4016e73fe658 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.31e-05 | 156 | 162 | 6 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.31e-05 | 156 | 162 | 6 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.31e-05 | 156 | 162 | 6 | 896e2d958be0a5c62fb6eebad2dfb7e1ce69f3ad | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.39e-05 | 167 | 162 | 6 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.39e-05 | 167 | 162 | 6 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.39e-05 | 167 | 162 | 6 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 169 | 162 | 6 | cd16e8462ee09877be962fbd9a3badcb825820b0 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.74e-05 | 170 | 162 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1_VIP_PCDH20|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.00e-05 | 172 | 162 | 6 | 35e961c88bfe79046533396912cedf00ca81db7b | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.13e-05 | 173 | 162 | 6 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.13e-05 | 173 | 162 | 6 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| ToppCell | Adult-Epithelial-basal_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.26e-05 | 174 | 162 | 6 | a4f98afe7d1cc2617f6f7bc8092c41df57474b30 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.40e-05 | 175 | 162 | 6 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 176 | 162 | 6 | b4a23d8d1414434adeb237a96f28c825f1aebd77 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 176 | 162 | 6 | 66c9c6b59030f67e8d746a9c6930e50923f2ded1 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.54e-05 | 176 | 162 | 6 | fc5787946f5a10056d326d070620575ae4081836 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.54e-05 | 176 | 162 | 6 | 5daaba0853afe7d20d4635169ccd4f96e735b938 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.69e-05 | 177 | 162 | 6 | 1cb78133ac09ea3a3f5b5de07151033998406512 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.69e-05 | 177 | 162 | 6 | 88403b055eb9fdf96e4695fb6e0d78179e30a1e3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.69e-05 | 177 | 162 | 6 | 8903aeaab61abd81a148ea623038c5114b8a183b | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.84e-05 | 178 | 162 | 6 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 178 | 162 | 6 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.99e-05 | 179 | 162 | 6 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.99e-05 | 179 | 162 | 6 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.99e-05 | 179 | 162 | 6 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.15e-05 | 180 | 162 | 6 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.15e-05 | 180 | 162 | 6 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | critical-Lymphoid-NK|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.15e-05 | 180 | 162 | 6 | 5abf778395392244daaec876f306ed7e4f388686 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.15e-05 | 180 | 162 | 6 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.31e-05 | 181 | 162 | 6 | 70eff83dd85691e977972c660731394d2fcf5cdf | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.31e-05 | 181 | 162 | 6 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.31e-05 | 181 | 162 | 6 | ab0f300d14b62cef57f1b0bdae143b8dfe8e6975 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-05 | 181 | 162 | 6 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.31e-05 | 181 | 162 | 6 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.47e-05 | 182 | 162 | 6 | da61e7cb2537c567968d8bd8baf537ecdff0ab18 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.47e-05 | 182 | 162 | 6 | dd1c59babf7211362452e3e264009d70004d99f6 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.47e-05 | 182 | 162 | 6 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| Disease | lymphocyte measurement | 3.35e-06 | 117 | 158 | 7 | EFO_0803546 | |
| Disease | vital capacity | SHROOM3 PCDHA9 CACNA2D2 EPB41L4B UNC5B RBM20 MAP3K1 KCNH3 CABLES1 LZTS1 ACAN CCAR2 DOT1L SSBP4 MAPKBP1 TNS1 DAGLA SF3B2 PDE11A | 3.65e-05 | 1236 | 158 | 19 | EFO_0004312 |
| Disease | Abnormal behavior | 8.01e-05 | 16 | 158 | 3 | C0233514 | |
| Disease | obesity (implicated_via_orthology) | 1.66e-04 | 215 | 158 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | Herlitz Disease | 1.70e-04 | 4 | 158 | 2 | C0079683 | |
| Disease | Epidermolysis Bullosa Progressiva | 1.70e-04 | 4 | 158 | 2 | C0079297 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 2.82e-04 | 5 | 158 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 2.82e-04 | 5 | 158 | 2 | C2608084 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 2.82e-04 | 5 | 158 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | hematocrit | SHROOM3 SLC10A4 UBQLN4 FBRSL1 ZC3HC1 PRR12 PRDM8 KLF1 ATXN2 ZC3H4 ZMIZ2 IRS2 C1orf210 DOT1L PROX1 | 3.66e-04 | 1011 | 158 | 15 | EFO_0004348 |
| Disease | Junctional Epidermolysis Bullosa | 4.21e-04 | 6 | 158 | 2 | C0079301 | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 5.88e-04 | 7 | 158 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | insulin measurement | 6.14e-04 | 267 | 158 | 7 | EFO_0004467 | |
| Disease | mean arterial pressure, unipolar depression | 6.67e-04 | 32 | 158 | 3 | EFO_0003761, EFO_0006340 | |
| Disease | microcephaly (implicated_via_orthology) | 6.67e-04 | 32 | 158 | 3 | DOID:10907 (implicated_via_orthology) | |
| Disease | asthma | LRRC32 MUC16 TNFRSF11A FOXA3 PRAG1 STAC ITPKB USP10 EPS15L1 ATXN2 ARHGAP27 PBX2 | 7.58e-04 | 751 | 158 | 12 | MONDO_0004979 |
| Disease | interleukin 10 measurement | 8.30e-04 | 78 | 158 | 4 | EFO_0004750 | |
| Disease | FEV/FEC ratio | SELPLG CHAF1B FRAS1 LRRC32 MAP3K1 PRR12 DES HOXB1 FCGBP RPAP1 ACAN CNTNAP2 PBX2 TNS1 MRTFA JPH3 | 9.46e-04 | 1228 | 158 | 16 | EFO_0004713 |
| Disease | Tendinopathy | 1.00e-03 | 9 | 158 | 2 | EFO_1001434 | |
| Disease | urea measurement | 1.25e-03 | 10 | 158 | 2 | EFO_0011005 | |
| Disease | initial pursuit acceleration | 1.25e-03 | 87 | 158 | 4 | EFO_0008434 | |
| Disease | systemic lupus erythematosus | SHROOM3 PCNX3 FBRSL1 ZNF831 POM121C PRAG1 EPS15L1 PRR14 ATXN2 ARHGAP27 DOT1L SSBP4 | 1.29e-03 | 799 | 158 | 12 | MONDO_0007915 |
| Disease | Colorectal Carcinoma | TCOF1 ISLR CABLES1 KMT2C RPAP1 GSE1 TRIM28 TENM1 DCHS1 VWA2 JPH3 | 1.46e-03 | 702 | 158 | 11 | C0009402 |
| Disease | oral microbiome measurement | 1.48e-03 | 42 | 158 | 3 | EFO_0801229 | |
| Disease | nucleus accumbens volume change measurement | 1.52e-03 | 11 | 158 | 2 | EFO_0021493 | |
| Disease | hypertrophic cardiomyopathy | 1.53e-03 | 92 | 158 | 4 | EFO_0000538 | |
| Disease | mean arterial pressure, alcohol drinking | 1.93e-03 | 98 | 158 | 4 | EFO_0004329, EFO_0006340 | |
| Disease | cryptic phenotype measurement | 2.06e-03 | 47 | 158 | 3 | EFO_0021487 | |
| Disease | putamen volume change measurement | 2.14e-03 | 13 | 158 | 2 | EFO_0021495 | |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 2.32e-03 | 49 | 158 | 3 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 | |
| Disease | obsolete_red blood cell distribution width | TBC1D5 C19orf47 FBRSL1 ZC3HC1 FOXA3 ABCA7 MAP3K1 GAREM2 KLF1 TMEM259 ZC3H4 IRS2 ARHGAP27 SSBP4 DAGLA ARMH4 | 2.43e-03 | 1347 | 158 | 16 | EFO_0005192 |
| Disease | Alopecia, Male Pattern | 2.86e-03 | 15 | 158 | 2 | C4083212 | |
| Disease | Ischemic stroke, tissue plasminogen activator measurement | 2.86e-03 | 15 | 158 | 2 | EFO_0004791, HP_0002140 | |
| Disease | Androgenetic Alopecia | 2.86e-03 | 15 | 158 | 2 | C0162311 | |
| Disease | Female pattern alopecia (disorder) | 2.86e-03 | 15 | 158 | 2 | C0263477 | |
| Disease | myocardial infarction | 2.88e-03 | 350 | 158 | 7 | EFO_0000612 | |
| Disease | diastolic blood pressure, alcohol consumption measurement | 3.06e-03 | 54 | 158 | 3 | EFO_0006336, EFO_0007878 | |
| Disease | Ischemic stroke, plasminogen activator inhibitor 1 measurement | 3.25e-03 | 16 | 158 | 2 | EFO_0004792, HP_0002140 | |
| Disease | coronary thrombosis, GM11992 | 3.25e-03 | 16 | 158 | 2 | EFO_0001124, EFO_1000883 | |
| Disease | preeclampsia, hypertension, pregnancy-induced | 3.25e-03 | 16 | 158 | 2 | EFO_0000668, MONDO_0024664 | |
| Disease | preeclampsia, parental genotype effect measurement | 3.25e-03 | 16 | 158 | 2 | EFO_0000668, EFO_0005939 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 3.25e-03 | 16 | 158 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | plasma beta-amyloid 1-40 measurement | 3.68e-03 | 17 | 158 | 2 | EFO_0005659 | |
| Disease | factor XI measurement, Ischemic stroke | 3.68e-03 | 17 | 158 | 2 | EFO_0004694, HP_0002140 | |
| Disease | squamous cell carcinoma (is_implicated_in) | 4.12e-03 | 18 | 158 | 2 | DOID:1749 (is_implicated_in) | |
| Disease | disease free survival | 4.12e-03 | 18 | 158 | 2 | EFO_0000409 | |
| Disease | asthma, Eczema, allergic rhinitis | 4.14e-03 | 121 | 158 | 4 | EFO_0005854, HP_0000964, MONDO_0004979 | |
| Disease | lifestyle measurement, maximum cigarettes per day measurement | 4.26e-03 | 122 | 158 | 4 | EFO_0009264, EFO_0010724 | |
| Disease | Alzheimer disease, polygenic risk score | 4.45e-03 | 586 | 158 | 9 | EFO_0030082, MONDO_0004975 | |
| Disease | Pseudopelade | 4.59e-03 | 19 | 158 | 2 | C0086873 | |
| Disease | Alopecia | 4.59e-03 | 19 | 158 | 2 | C0002170 | |
| Disease | factor VIII measurement, Ischemic stroke | 4.59e-03 | 19 | 158 | 2 | EFO_0004630, HP_0002140 | |
| Disease | leukemia (implicated_via_orthology) | 4.59e-03 | 19 | 158 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | lymphocyte:monocyte ratio | 4.68e-03 | 288 | 158 | 6 | EFO_0600088 | |
| Disease | myeloid white cell count | UBQLN4 ZC3HC1 ABCA7 CIC EPS15L1 ATXN2 PKD1 MED12L AKAP11 DOT1L SSBP4 TNS3 | 4.70e-03 | 937 | 158 | 12 | EFO_0007988 |
| Disease | monocyte count | C3orf22 CIC MEF2D CABLES1 GSE1 ATXN2 ZMIZ2 PKD1 MED12L FCRLB IRS2 SSBP4 VWA2 MRTFA TNS3 | 4.97e-03 | 1320 | 158 | 15 | EFO_0005091 |
| Disease | coronary artery disease | SHROOM3 DSCAM PCNX3 HCN4 ZC3HC1 ZNF831 FOXA3 MAP3K1 PRDM8 ATXN2 PBX2 TNS1 MRTFA TNS3 | 5.04e-03 | 1194 | 158 | 14 | EFO_0001645 |
| Disease | susceptibility to cold sores measurement | 5.16e-03 | 65 | 158 | 3 | EFO_0008402 | |
| Disease | parental longevity | 5.29e-03 | 494 | 158 | 8 | EFO_0007796 | |
| Disease | Tinnitus | 5.33e-03 | 130 | 158 | 4 | HP_0000360 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LVGSASFPGSPGSRR | 111 | Q8N944 | |
| PLPGGRNFSGTASTS | 11 | Q8N163 | |
| PGKALTGRSVGPSSA | 211 | Q8N350 | |
| GSPLNCGVGLPTSFT | 326 | Q5U5X8 | |
| TPGPDSSGSLGSGEF | 366 | Q9UBC2 | |
| DPFSRPSTFGGLGSL | 681 | Q9HCM7 | |
| GLSSRTFGPSGSLPS | 526 | P55198 | |
| FSGRGSASLTAPPGR | 96 | Q5T6M2 | |
| RGADLGSFPGSPGTS | 221 | O95196 | |
| GRGASFPPSLGVLVS | 1111 | Q9NY47 | |
| GSKPTGVFSRLGATP | 256 | Q8N9M1 | |
| GSPGGLGLESLSPEF | 686 | P46379 | |
| PPGCGKSSFITALAG | 231 | Q9Y276 | |
| LFLPAAGAGRTPSGS | 46 | Q6UXT8 | |
| FPGAESTAGSEPGSL | 236 | Q86TY3 | |
| AATFGELSGPLKPGS | 696 | Q14687 | |
| SSLSIFAGPAVGLSP | 266 | A6NJG6 | |
| SFTPDGSLLLTPAGC | 241 | Q13112 | |
| IRLPSGSGAASPTGS | 206 | Q09666 | |
| LFSPIRSSAFSPLGG | 446 | Q9UKA4 | |
| RSSAFSPLGGCTPAE | 451 | Q9UKA4 | |
| SGALAGSPASLTPGA | 946 | Q8TEK3 | |
| FPGSLSGADGLSPGT | 1296 | Q8TEK3 | |
| NPDGTPALSTLGGFS | 321 | Q9UK58 | |
| RGLGAPDFTSPSGSC | 71 | Q8N5N4 | |
| PGALGSLSSRSAFSP | 426 | Q96SC8 | |
| LSILSGLFPPSGGSA | 851 | Q8IZY2 | |
| GQPGFLPSSASTSGS | 246 | Q5T481 | |
| SGAVSGASGFLPPAR | 16 | Q9H082 | |
| AFSPGLSPCAGSTER | 771 | Q9Y5H5 | |
| TLTALDGGAPPRSGT | 211 | Q9Y5E4 | |
| TSLLAETLGPGGGFP | 121 | P20936 | |
| LTLTAVDGGSPPRSG | 156 | Q96TA0 | |
| ASGEGPCPASTSGLL | 921 | Q9ULD8 | |
| TGIPARFSGSGPGTD | 76 | A0A0A0MRZ8 | |
| GTDLALAPASSAGPG | 31 | Q96EP9 | |
| VSPSPQSTCGGLLSG | 136 | Q9BY79 | |
| TTGVPRAISGSGSPF | 10291 | Q8WXI7 | |
| SLGAGLGSSGSPPFR | 616 | Q96JQ0 | |
| ATAFLGGCGLSPAPT | 3116 | Q96JQ0 | |
| LAPSPSGMAGLSFGT | 626 | Q96RG2 | |
| TPPSSAGSGGSFNLS | 336 | P40425 | |
| LLPSFSTFASGPAGR | 16 | O43474 | |
| APRLAVSPGGSTSVG | 1601 | Q86XX4 | |
| SLPPGSGLGTFSAIA | 1576 | Q8NEZ4 | |
| SLTPGGSRLDPAGSF | 1831 | Q86YW9 | |
| LVTPVGPTSRFGGSA | 196 | Q9Y250 | |
| PSSSFGVSSCLGGPL | 3141 | Q16787 | |
| VKAPFLGSGGTIAPS | 421 | Q96PY6 | |
| APSSVVAATSGGGRP | 226 | Q99700 | |
| GSCSVFSSPKTPGGF | 3691 | Q2LD37 | |
| SPASGSRGGFVLAGP | 186 | Q96JJ6 | |
| APPALGGGCLGTFTS | 6 | Q9GZN4 | |
| RVGSFGSSPPGLSST | 6 | Q9Y6G9 | |
| TASAVAPGPGTGARA | 16 | Q8IVY1 | |
| GTDGRALPGTPVASS | 286 | O14498 | |
| SFDTVIGAGTPPGLA | 361 | Q9H6A9 | |
| APGSRTGTAGVPSAT | 7011 | Q7Z5P9 | |
| SGVAPGTTVAPGSFS | 7686 | Q7Z5P9 | |
| ALPGGFRTGNTPGST | 8041 | Q7Z5P9 | |
| SPAGAGTPEAGATSL | 386 | O95206 | |
| QGALGPRPSLAGTSS | 46 | Q9HCR9 | |
| CALGGSLGSLPASPF | 691 | O14511 | |
| ILASSGFGAPLPSSS | 466 | Q7LBC6 | |
| LGTPPGGDVCSSDSF | 91 | Q99687 | |
| PGLGLCSSSPTGDFV | 146 | Q6ZTU2 | |
| SFLAASGPGSTPLGA | 311 | Q9H2C1 | |
| SGSGPFSPRLGVTGE | 61 | A0A087WXM9 | |
| APSAGSSLFSTGVAP | 476 | Q9NZ52 | |
| LLGPTFPGLSSCSAD | 166 | P10275 | |
| SSLLAGGSGSRPSPE | 91 | P06850 | |
| LPGSAFTLSTPSAPG | 1631 | P16144 | |
| SLFGARATSSGGPPL | 1166 | Q9Y3Q4 | |
| SGQAPETSGLPSGFS | 1616 | P16112 | |
| SGQPSGLPGFSGATS | 1796 | P16112 | |
| GLPGFSGATSGVPDL | 1801 | P16112 | |
| PAASSFGSPGFSGLP | 306 | O15504 | |
| FGSPGFSGLPASLAT | 311 | O15504 | |
| FSGLPASLATGPVRA | 316 | O15504 | |
| PFGSAAPSFSIGAGS | 1196 | A8CG34 | |
| PFGSAAPSFSIGAGS | 801 | A6NF01 | |
| PGPSGCVAFSGITSL | 431 | Q14392 | |
| APTSAAGRTFPASGG | 711 | Q9Y4H2 | |
| GSLSRHPSSQLAGPG | 241 | Q7Z6L0 | |
| FTTGCSTLPPGGLAN | 2541 | Q9ULT8 | |
| SEPGLGSPSGLRTNF | 196 | P14653 | |
| PGGALPECFGTTDTT | 1056 | Q9Y2F5 | |
| TSPSFLSCLGPGTVG | 231 | Q13351 | |
| TVSGPGVARGFASPL | 156 | Q8TDN4 | |
| TTGCPGVSTQGLTPF | 1701 | Q9Y6R7 | |
| EFCGLLSSPTGPLSS | 3861 | Q9Y6R7 | |
| SSPVFPRAGFGSKGS | 31 | P17661 | |
| PTLPGSFRLSSGADG | 481 | Q96PX6 | |
| ASDTTPLGAAVGGPS | 591 | Q4ZIN3 | |
| VAGAVLSSPGSSPGA | 1471 | O60336 | |
| FAGSADPSSGISLSP | 976 | Q9Y4D2 | |
| ATGGRPGTSPALFSG | 51 | Q9H078 | |
| PGTSPALFSGRGAAT | 56 | Q9H078 | |
| FGGIPFSGKPSSSSR | 316 | Q9UHC6 | |
| GRPGTEGSTSLSAPA | 56 | Q9HBU6 | |
| STGLQFPASGAPTAG | 336 | Q6BAA4 | |
| AGGAPAAPQTSTSLG | 976 | Q9NZM4 | |
| SGLGFGPPTSLASAS | 156 | P53992 | |
| SLAPGSRAPIAGFSS | 2156 | Q58EX2 | |
| GPRGGPAAAASSSAL | 36 | Q9H329 | |
| LSPGAKSPSDRGGAF | 736 | Q9H329 | |
| PSSGSPERGGDGLTF | 786 | Q8N137 | |
| GSGGGSTAQSFLRPP | 406 | Q9UJU5 | |
| PAAGSSGPFSASLSL | 341 | Q8WUT4 | |
| SAELSSLPAFSSPGG | 341 | Q14814 | |
| SLPAFSSPGGLSLGN | 346 | Q14814 | |
| PVSGLSIRASEPGGS | 1801 | P98161 | |
| SSGFPGARATSPEAG | 11 | Q13233 | |
| SSSVVFPGGGASAPS | 406 | Q6ZN04 | |
| GPGVTANPGTSLSVF | 61 | Q5VT03 | |
| FASTTGTLVPCPAAG | 36 | O60469 | |
| GPSAALSSGPRTTSG | 641 | Q75VX8 | |
| GSGSPPLRVSVGDSS | 556 | Q8N2Y8 | |
| SSLLPDGGEGPSATA | 366 | Q14242 | |
| ASLRFTLPGSGTEGP | 41 | Q9GZN7 | |
| SLGFPVGGPGTSLSL | 566 | P49589 | |
| TATSPAGSSPAVAGG | 671 | Q13428 | |
| GIGTFPLPDSGNRST | 1721 | O14513 | |
| VLSPGSVFSPGRGAS | 41 | P27987 | |
| PTFPGLGVSGGSSSS | 76 | P55318 | |
| GGSPARGSAFTSVPQ | 451 | Q9NQV8 | |
| PLGAPSGSFSGKDRA | 496 | Q92786 | |
| PLGGVGASPSLTTSC | 386 | Q9BWN1 | |
| SPPAGLLGSSGSFKA | 166 | Q6ZUM4 | |
| ASLGAATSSPRSGPG | 1341 | O43166 | |
| GGCTFSGIFPTLTSP | 1981 | Q8TF72 | |
| SPLTSFGGSCPERGT | 991 | Q9UKZ4 | |
| FVIPGRSSGCSTPSG | 126 | Q53GG5 | |
| RLIPNATGTGTFSPG | 521 | Q16512 | |
| GPTELFISGALPGSS | 126 | Q9ULL5 | |
| PGAFLIRPSESSLGG | 141 | Q9H3Y6 | |
| LGSGRPTGSPLSAEF | 961 | Q68CZ2 | |
| AGEALGSSGTPPVRS | 296 | Q969V6 | |
| AGLLGSPMGTASSFP | 366 | Q6PIS1 | |
| GGLLSPSTPFGASNL | 376 | Q9UPE1 | |
| SSVALGFTSLGPSGP | 1036 | Q96RK0 | |
| SIPVGSFEAGASGRP | 1186 | Q96RK0 | |
| ASFGLTSSPIPGLEG | 296 | Q86WB0 | |
| SHGRNSPGLGSLVSP | 506 | Q8ND24 | |
| ADSGLITPGGFSSVP | 741 | Q13435 | |
| GSPVGSALSTKFGPR | 66 | Q7RTY0 | |
| GTPSNSIGFGAAPST | 1121 | Q12816 | |
| KVGAPSRGALSPSGS | 666 | Q13207 | |
| AAGSTPGSPVFLSAA | 156 | Q8TEJ3 | |
| PGSPVFLSAAAGSTA | 161 | Q8TEJ3 | |
| SSPGAVAGLSNAPGT | 341 | Q9BWG4 | |
| SLTSTPARAGLHPGG | 91 | Q99469 | |
| LRNGTLGGSFVSPSP | 1061 | Q9HBL0 | |
| LESGFRSGSLGQPSP | 1111 | Q9HBL0 | |
| DGIPFRGGPTLTGSA | 411 | Q5GFL6 | |
| ARFTLGSPLTSPGGS | 201 | Q12968 | |
| SGGCPRLSLAGSASP | 876 | Q9BWH6 | |
| GSLQTGLPESFPLTG | 1151 | Q96JH7 | |
| GLPRDPGSSVSGTFG | 536 | Q8IZJ1 | |
| GNAFTGLGPVSTLPS | 551 | Q9NNW5 | |
| PVSPLADLSDGSSGG | 566 | Q86YV5 | |
| ASASARGPPATDGLG | 411 | Q9UFB7 | |
| AAGTDPSSPVGFVLG | 96 | Q9UI43 | |
| RPPASVGELSSSGLG | 831 | Q9UPT8 | |
| ASLGPTGELAFSPAT | 851 | Q8NF64 | |
| LTSGSAGPAQPGSVA | 1056 | A7E2V4 | |
| SLGCSKPAGSSPLAG | 401 | Q96F45 | |
| DSTSGLRPCGSPGSF | 191 | Q8N446 | |
| SPFPGALGSDTRTAG | 226 | Q14694 | |
| AAVAPGGLQSTPGRS | 441 | O60346 | |
| APPFSSSSGVLGTGL | 76 | O43294 | |
| SVESLPGGREFTGSP | 541 | Q92609 | |
| RASFVGSGLGTPLSP | 976 | Q5JPB2 | |
| GSFGISRTPAPSAGS | 491 | Q9NRR5 | |
| GSTSPLGFARASPSP | 466 | O75385 | |
| SISAPGPLGSSEGSR | 491 | Q9BU19 | |
| GAEGPRLASPSGSTS | 586 | Q13263 | |
| LPSSARAGAGSGSSP | 501 | Q9Y6Q6 | |
| ASPAVAGSPAVSRGG | 181 | Q8WXH2 |